News
Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...
21h
Khaleej Times on MSNUAE retail investors charged into EV, tech, and telehealth stocks in Q2 2025According to data from eToro, leading the list was telehealth platform, Hims & Hers Health, which surged 85 per cent in ...
4h
AirlineGeeks on MSNPilot Sues United Over Forced Rehab and TerminationVeteran captain alleges he was wrongly diagnosed with alcohol dependence following a head injury and coerced into United's ...
The federal government's investigation into a recall of Salmonella-contaminated brown cage-free and certified-organic eggs ...
People with "young" brains -- brains aging more slowly than their actual age -- are much less likely to die or develop ...
Mukesh Ambani Reliance Jio backed KareXpert is operational in 500-plus hospitals and medical centres, serving over 15 million ...
Explore more
Ghana News Agency (GNA) on MSN21h
GHIMA raises concern over poor investment in health information systemsRichard Delali Ahedor, the National President of the Ghana Health Information Management Association (GHIMA), has raised ...
22h
Zacks Investment Research on MSNReasons to Add Fresenius Medical Stock to Your Portfolio NowFresenius Medical Care AG & Co. FMS is well-poised for growth on the back of strategic acquisitions and partnerships and a solid global foothold. However, a tough regulatory environment remains a ...
Welcome to The Globe and Mail’s business and investing news quiz. Join us each week to test your knowledge of the stories making headlines. Our business reporters come up with the questions, and you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results